Survival benefit of thoracic radiotherapy plus EGFR-TKIs in patients with non-oligometastatic advanced non-small-cell lung cancer: a single-center retrospective study

OBJECTIVES: The study aims to evaluate the efficacy and safety of thoracic radiotherapy in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-treated patients with stage IV non-small-cell lung cancer (NSCLC). METHODS: Patients with non-oligometastatic NSCLC harboring EGFR mutati...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Fangyuan, Qin, You, Liu, Xixi, Huang, Jing, Wu, Bian, Zhang, Zhanjie, Yin, Zhongyuan, Yang, Jinsong, Zhang, Sheng, Jiang, Ke, Yang, Kunyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031612/
https://www.ncbi.nlm.nih.gov/pubmed/36970112
http://dx.doi.org/10.1177/17588359231161411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031612/
https://www.ncbi.nlm.nih.gov/pubmed/36970112
http://dx.doi.org/10.1177/17588359231161411

Ejemplares similares